T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in T2 Biosystems, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +5 vs. Q3 2024
- Shares held
- 871.8K
- −1.28M (−59.5%) vs. Q3 2024
- Total value
- $365.9K
- −$3.87M (−91.4%) vs. Q3 2024
- New holders
- 9
- 5 more added
- Sold out
- 4
- 4 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTOO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 2 | $0 |
| Q4 2025 | 2 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 26 | $365.9K |
| Q3 2024 | 21 | $4.24M |
| Q2 2024 | 21 | $12.6M |
| Q1 2024 | 19 | $519.8K |
| Q4 2023 | 21 | $1.37M |
| Q3 2023 | 44 | $4.06M |
| Q2 2023 | 32 | $451.5K |
| Q1 2023 | 34 | $1.55M |
| Q4 2022 | 27 | $667.5K |
| Q3 2022 | 62 | $2.79M |
| Q2 2022 | 68 | $3.07M |
| Q1 2022 | 76 | $7.97M |
| Q4 2021 | 79 | $9.92M |
| Q3 2021 | 79 | $21.1M |
| Q2 2021 | 84 | $33.0M |
| Q1 2021 | 84 | $42.6M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding T2 Biosystems, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 271 | $0 | 0.00% | −3,730−93.2% | Reduced |
| CWM, LLC | 310 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $0 | 0.00% | −100−99.0% | Reduced |
| US Bancorp | 3 | $1 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 14 | $6 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 33 | $14 | 0.00% | +33 | New |
| Advisor Group Holdings, Inc. | 38 | $15 | 0.00% | −167−81.5% | Reduced |
| Bank of America Corp | 82 | $34 | 0.00% | +26+46.4% | Added |
| SBI Securities Co., Ltd. | 99 | $42 | 0.00% | +99 | New |
| Citigroup Inc | 237 | $100 | 0.00% | +237 | New |
| Group One Trading, L.P. | 289 | $121 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,304 | $2.23K | 0.00% | +2,905+121.1% | Added |
| Nordwand Advisors, LLC | 10,000 | $4.20K | 0.00% | +10,000 | New |
| Two Sigma Investments, LP | 11,936 | $5.01K | 0.00% | +11,936 | New |
| Goldman Sachs Group Inc | 14,750 | $6.20K | 0.00% | 00.0% | Unchanged |
| Kingswood Wealth Advisors, LLC | 20,000 | $8.40K | 0.00% | +20,000 | New |
| Two Sigma Securities, LLC | 22,814 | $9.58K | 0.00% | +22,814 | New |
| Northern Trust Corp | 27,142 | $11.4K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 31,162 | $13.0K | 0.00% | +31,162 | New |
| Susquehanna International Group, LLP | 57,554 | $24.2K | 0.00% | +12,073+26.5% | Added |
| State Street Corp | 63,743 | $26.8K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 76,827 | $32.3K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 92,983 | $39.1K | 0.00% | +92,983 | New |
| UBS Group AG | 139,240 | $58.5K | 0.00% | +139,239+13,923,900.0% | Added |
| Geode Capital Management, LLC | 142,196 | $59.8K | 0.00% | +51,316+56.5% | Added |
| Vanguard Group Inc | 154,814 | $65.0K | 0.00% | −235,554−60.3% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,396,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −39,140−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −65−100.0% | Sold out |